Tower Research Capital LLC (TRC) - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 67 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$1,0002,177
+2077.0%
0.00%
Q2 2015$0
-100.0%
100
-98.9%
0.00%
-100.0%
Q1 2015$10,000
-56.5%
9,519
-55.8%
0.00%
-50.0%
Q4 2014$23,000
-37.8%
21,536
-36.9%
0.00%
-50.0%
Q3 2014$37,000
+48.0%
34,148
+40.4%
0.00%
+33.3%
Q2 2014$25,000
+47.1%
24,314
+44.3%
0.00%
+50.0%
Q1 2014$17,00016,8460.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders